About this trial
In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally represents the primary treatment strategy. Among factors determining the disease prognostic, the surgical margins status is essential for the continued management of the patient, with or without complementary therapies. Generally, surgical margins are defined using visual and tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive after histopathological examination, on average 5 to 7 days post-surgery.
Techniques have recently been developed to analyze the cancerous and non-cancerous nature of tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical tool to precisely define cancerous areas in situ and the margins status in intraoperative conditions.
Based on the principle of artificial intelligence, the SpiderMass™ machine must initially learn to recognize pathological tissues versus healthy. This project aims to accomplish this first phase of machine learning for squamous cell carcinoma of the tongue.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age : 18 years and older
squamous cell carcinoma of the tongue
surgical resection as first-line treatment
tumor classification T1 to T4.
Disqualifiers
metastatic disease
neoadjuvant therapies
Trial population
Patients treated in the Maxillofacial Surgery Department of the CHU Amiens-Picardie for a squamous cell carcinoma of the tongue and for whom the first-line treatment is surgical resection
Trial design
Case-only
Prospective
Treatments tested in this trial
tongue surgery
Procedure/SurgeryIn squamous cell carcinoma of the tongue, complete surgical resection of the tumor
Treatment groups
Trial outcomes
Primary outcomes
Tumor cells detection in tongue tumor with SpiderMass technique
Tumor cells detection in tongue tumor with SpiderMass technique
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Université de Lille
Collaborator